A Study of DZD8586 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Condition:   Lymphoma, Non-Hodgkin Intervention:   Drug: DZD8586 Sponsor:   Dizal Pharmaceuticals Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials